Literature DB >> 18085378

Immunohistochemical and immunoelectron microscopic studies of the localization of KL-6 and epithelial membrane antigen (EMA) in presumably normal pulmonary tissue and in interstitial pneumonia.

Yuji Ohtsuki1, Jiro Fujita, Yasuki Hachisuka, Masashi Uomoto, Yuhei Okada, Takeo Yoshinouchi, Gang-Hong Lee, Mutsuo Furihata, Nobuoki Kohno.   

Abstract

To clarify the localization of KL-6 and epithelial membrane antigen (EMA) in human lungs, immune reactions to antibodies to these factors were examined in detail at light and electron microscopic levels. Immunohistochemical investigation was performed in 17 cases of usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP), hypersensitivity pneumonitis (HP), collagen vascular disease-associated interstitial pneumonias (CVD-IP), viral pneumonia, and bronchobronchioloectasis, as well as in 10 cases of presumably normal pulmonary tissue resected as a result of spontaneous pneumothorax. Immunohistochemical study revealed similar discontinuous linear or dome-shaped positive patterns restricted to type II alveolar cells in presumably normal tissue and only some regions of interstitial pneumonia. In sharp contrast, immune reactions with each of the two antibodies yielded a continuous linear pattern surrounding damaged areas in most regions of interstitial pneumonias and some normal areas as well. Staining for EMA antibody was negative in some regenerating alveolar and bronchial cells in regenerating foci in interstitial pneumonias, although staining for KL-6 antibody was always positive in these cells. Immunoelectron microscopic studies demonstrated similar positive reactions with both antibodies on the surface of alveolar epithelial cells in three of the cases examined, with surface positive granules 100-200 nm in diameter. Thus, although staining for both KL-6 and EMA antibodies exhibited discontinuous positivity restricted to type II alveolar cells in nondamaged regions, immune reactions were continuous and linear in pattern in or around damaged areas of the lungs at both light and electron microscopic levels, probably as a consequence of cell-surface barrier function. These findings in pulmonary tissue might be evidence of defense functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085378     DOI: 10.1007/s00795-007-0382-7

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  14 in total

1.  New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6.

Authors:  N Kohno; S Kyoizumi; Y Awaya; H Fukuhara; M Yamakido; M Akiyama
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

2.  Assay of epithelial membrane antigen (EMA) in human serum by ELISA.

Authors:  J C Hendrick; F Gilis; P Franchimont
Journal:  Eur J Cancer Clin Oncol       Date:  1986-10

3.  Ultrastructural study of nuclear inclusions immunohistochemically positive for surfactant protein A in pulmonary adenocarcinoma with special reference to their morphogenesis.

Authors:  Shu-Hui Lu; Yuji Ohtsuki; Yoshiki Nonami; Shiro Sasaguri; Jiro Fujita; Masashi Uomoto; Fu-Shan Tao; Makoto Kobayashi; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2006-12-21       Impact factor: 2.309

4.  Ultrastructural localization of carcinoembryonic antigen (CEA) glycoproteins and epithelial membrane antigen (EMA) in normal and neoplastic sweat glands.

Authors:  D Metze; T A Luger
Journal:  J Cutan Pathol       Date:  1996-12       Impact factor: 1.587

5.  Immunohistochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias.

Authors:  Yuji Ohtsuki; Norihiko Nakanishi; Jiro Fujita; Takeo Yoshinouchi; Makoto Kobayashi; Nobuo Ueda; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

6.  Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9.

Authors:  N Kohno; Y Inoue; H Hamada; S Fujioka; S Fujino; A Yokoyama; K Hiwada; N Ueda; M Akiyama
Journal:  Int J Cancer Suppl       Date:  1994

7.  KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.

Authors:  N Kohno; Y Awaya; T Oyama; M Yamakido; M Akiyama; Y Inoue; A Yokoyama; H Hamada; S Fujioka; K Hiwada
Journal:  Am Rev Respir Dis       Date:  1993-09

8.  Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.

Authors:  N Kohno; M Akiyama; S Kyoizumi; M Hakoda; K Kobuke; M Yamakido
Journal:  Jpn J Clin Oncol       Date:  1988-09       Impact factor: 3.019

9.  KL-6, a human MUC1 mucin, is expressed early in premature lung.

Authors:  A P Sun; Y Ohtsuki; J Fujita; T Ishida; T Yoshinouchi; N Kohno
Journal:  Respir Med       Date:  2003-08       Impact factor: 3.415

10.  Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry.

Authors:  J Cordell; T C Richardson; K A Pulford; A K Ghosh; K C Gatter; E Heyderman; D Y Mason
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

View more
  12 in total

1.  A rare case of coexistence of pulmonary adenocarcinoma with Langerhans' cell histiocytosis.

Authors:  Yuji Ohtsuki; Masashi Uomoto; Yasuki Hachisuka; Miyuki Kato; Mitsuko Iguchi; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2008-09-20       Impact factor: 2.309

Review 2.  Molecular biomarkers in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Kevin K Brown; Harold R Collard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-26       Impact factor: 5.464

3.  Immunohistochemical and ultrastructural characterization of the signet-ring cell carcinoma component in a case of urothelial carcinoma of the urinary bladder.

Authors:  Yuji Ohtsuki; Tetsuya Fukumoto; Yuhei Okada; Yuki Teratani; Yoshihiro Hayashi; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2010-08-04       Impact factor: 2.309

4.  Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia.

Authors:  Yuji Ohtsuki; Ryohei Watanabe; Masashi Kimura; Katsuyoshi Nomura; Tomoharu Maeda; Katsumi Kito; Miyuki Takeji; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2014-06-08       Impact factor: 2.309

5.  KL-6 is another useful marker in assessing a micropapillary pattern in carcinomas of the breast and urinary bladder, but not the colon.

Authors:  Yuji Ohtsuki; Naoto Kuroda; Tatsuo Umeoka; Ryohei Watanabe; Kenji Ochi; Yuhei Okada; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

6.  Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.

Authors:  Masahiko Shigemura; Yasuyuki Nasuhara; Satoshi Konno; Chikara Shimizu; Kazuhiko Matsuno; Etsuro Yamguchi; Masaharu Nishimura
Journal:  J Transl Med       Date:  2012-07-11       Impact factor: 5.531

7.  Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets.

Authors:  Yasushi Horimasu; Nobuhisa Ishikawa; Masaya Taniwaki; Kakuhiro Yamaguchi; Kosuke Hamai; Hiroshi Iwamoto; Shinichiro Ohshimo; Hironobu Hamada; Noboru Hattori; Morihito Okada; Koji Arihiro; Yuji Ohtsuki; Nobuoki Kohno
Journal:  BMC Med Genet       Date:  2017-08-18       Impact factor: 2.103

8.  A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic.

Authors:  Maria Alimova; Eriene-Heidi Sidhom; Abhigyan Satyam; Moran Dvela-Levitt; Michelle Melanson; Brian T Chamberlain; Seth L Alper; Jean Santos; Juan Gutierrez; Ayshwarya Subramanian; Elizabeth Grinkevich; Estefania Reyes Bricio; Choah Kim; Abbe Clark; Andrew Watts; Rebecca Thompson; Jamie Marshall; Juan Lorenzo Pablo; Juliana Coraor; Julie Roignot; Katherine A Vernon; Keith Keller; Alissa Campbell; Maheswarareddy Emani; Matthew Racette; Silvana Bazua-Valenti; Valeria Padovano; Astrid Weins; Stephen P McAdoo; Frederick W K Tam; Lucienne Ronco; Florence Wagner; George C Tsokos; Jillian L Shaw; Anna Greka
Journal:  bioRxiv       Date:  2020-06-30

Review 9.  Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.

Authors:  Anna Stainer; Paola Faverio; Sara Busnelli; Martina Catalano; Matteo Della Zoppa; Almerico Marruchella; Alberto Pesci; Fabrizio Luppi
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

10.  Peritoneal Malignant Mesothelioma with Epithelioid Type, Demonstrating High Serum and Ascitic KL-6 Levels: Immunohistochemical Analyses.

Authors:  Saifun Nahar; Manabu Nakamoto; Akira Hokama; Chiharu Kobashigawa; Masatoshi Kaida; Tetsu Kinjo; Tetsuo Hirata; Nagisa Kinjo; Masanao Saio; Naoki Yoshimi; Yuji Ohtsuki; Jiro Fujita
Journal:  Rare Tumors       Date:  2015-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.